income_group,target_pop,hs_constraints,vaccine_doses,vaccine,max_coverage,age_groups_covered,age_groups_covered_d3,vacc_start,dt,repetition,seeding_cases,variant_fold_reduction,dose_3_fold_increase,vacc_per_week,ab_model_infection,t_d3,mu_ab_infection,max_Rt,scenario,name,strategy
HIC,1000000,Present,2,Pfizer,0.9,15,5,1/1/2021,0.25,1,10,1,6,0.05,TRUE,180,1.9,5,1,counterfactual_abmodel,realistic
HIC,1000000,Present,2,Pfizer,0.9,15,5,1/1/2021,0.25,2,10,1,6,0.05,TRUE,180,1.9,5,2,counterfactual_abmodel,realistic
HIC,1000000,Present,2,Pfizer,0.9,15,5,1/1/2021,0.25,3,10,1,6,0.05,TRUE,180,1.9,5,3,counterfactual_abmodel,realistic
HIC,1000000,Present,2,Pfizer,0.9,15,5,1/1/2021,0.25,4,10,1,6,0.05,TRUE,180,1.9,5,4,counterfactual_abmodel,realistic
HIC,1000000,Present,2,Pfizer,0.9,15,5,1/1/2021,0.25,5,10,1,6,0.05,TRUE,180,1.9,5,5,counterfactual_abmodel,realistic
